Hypoglycemia will occur on school grounds in students with diabetes who are receiving glucose-lowering drugs. Hypoglycemia may be severe, in which a student is unconscious or comatose. Fast-acting carbohydrates remain the first line of treatment for nonsevere hypoglycemia but preparedness with emergency injectable or intranasal glucagon is ideal. Students may not have their own glucagon devices, so unassigned or undesignated glucagon for use with any student in which glucagon is part of their hypoglycemia treatment plan is critical. Several states have laws permitting undesignated glucagon in schools, and school nurses residing in states without such laws could strongly advocate their state legislators to enact similar laws to ensure students in the nurses’ care have access to this lifesaving treatment.
AbrahamM. B.KargesB.DovcK.NaranjoD.ArbelaezA. M.MbogoJ.JavelikarG.JonesT. W.MahmudF. H. (2022). ISPAD Clinical Practice Consensus Guidelines 2022: Assessment and management of hypoglycemia in children and adolescents with diabetes. Pediatric Diabetes, 23(8), 1322–1340. https://doi.org/10.1111/pedi.13443
2.
American Diabetes Association Professional Practice Committee. (2024a). 6. Glycemic goals and hypoglycemia: Standards of care in diabetes—2024. Diabetes Care, 47(Suppl. 1), S111–S125. https://doi.org/10.2337/dc24-S006
3.
American Diabetes Association Professional Practice Committee. (2024b). 14. Children and adolescents: Standards of care in diabetes—2024. Diabetes Care, 47(Suppl. 1), S258–S281. https://doi.org/10.2337/dc24-S014
4.
BattelinoT.TehranchiR.BaileyT.DovcK.MelgaardA.Yager StoneJ.WoernerS.von dem BergeT.DiMeglioL.DanneT. (2020). Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase 3, randomized controlled trial. Pediatric Diabetes, 22, 734–741. https://doi.org/10.1111/pedi.13220
5.
BuckinghamB.SherrJ.PrestrelskiS. J.ConoscentiV. (2022). Pharmacodynamics, pharmacokinetics, safety, and tolerability of a ready-to-use, room temperature, liquid stable glucagon administered via an autoinjector pen to youth with type 1 diabetes. Pediatric Diabetes, 23, 754–762. https://doi.org/10.1111/pedi.13360
ChengR.TalebN.WuZ.BouchardD.ParentV.Lalanne-MistrihM.-L.BoudreauV.MessierV.LacombeM.-J.GrouC.BrazeauA.-S.Rabasa-LhoretR. (2024). Managing impending nonsevere hypoglycemia with oral carbohydrates in type 1 diabetes: The REVERSIBLE Trial. Diabetes Care, 47(3), 476–482. https://doi.org/10.2337/dc23-1328
DreznerJ. A.RaoA. L.HeistandJ.BloomingdaleM. K.HarmonK. G. (2009). Effectiveness of emergency response planning for sudden cardiac arrest in the United States high schools with automated external defibrillators. Circulation, 120(6), 518–525. https://doi.org/10.1161/CIRCULATIONAHA.109.855890
Georgia General Assembly. (2023a). Gov. Brian Kemp Signs Rep. Doug Stoner’s legislation to allow schools to stock treatment for hypoglycemic emergencies. https://www.legis.ga.gov/legislation/64462
GomberA.WentzellK.HigginsL. A.VolkeningL. K.LaffelL. M. (2023). School nurses’ comfort with diabetes management and technology from 2012 to 2019. Diabetes Spectrum, 36(3), 205–210. https://doi.org/10.2337/ds22-0056
16.
HughesA. S.ChapmanK. S.NguyenH.LiuJ.BisphamJ.WingetM.WeinzimerS. A.WolfW. A. (2023). Severe hypoglycemia and the use of glucagon rescue agents: An observational survey in adults with type 1 diabetes. Clinical Diabetes, 41(3), 399–410. https://doi.org/10.2337/cd22-0099
JunaidiM. K.KrecicM. R.CloseN. C.ConoscentiV. (2024). Two-way crossover phase 1 bioequivalence and safety studies in healthy adults for a ready-to-use, room-temperature, liquid-stable glucagon administered by autoinjector, prefilled syringe, or vial and syringe. Journal of Diabetes Science and Technology, 18(6), 1399–1407. https://doi.org/10.1177/19322968231179164
LawrenceS. E.Albanese-O’NeillA.BesançonS.BlackT.BratinaN.ChaneyD.CogenF. R.CummingsE. A.MoreauE.PierceJ. S.RichmondE.MahmudF. H. (2022). ISPAD clinical practice consensus guidelines 2022: Management and support of children and adolescents with diabetes in school. Pediatric Diabetes, 23(8), 1478–1495. https://www.doi.org/10.1111/pedi.13432
21.
MaheswaranA. B.GimbarR. P.EisenbergY.LinJ. (2022). Hypoglycemia events in the emergency department. Endocrine Practice, 28, 372–377. https://doi.org/10.1016/j.eprac.2022.01.006
QuinnM.BaileyR.FosterN. C.SimmonsJ.EythE.RodriguezH.CorathersS.LevyC. J.SheanonN. M.WassermanR. M.SparlingD.AdkinsD.Albanese-O’NeillA.DesalvoD. J. (2019). 1277-P: Diabetes management supplies in youth with Type 1 diabetes: Don’t leave home without them! Diabetes, 68(Suppl. 1), 1277-P. https://doi.org/10.2337/db19-1277-P
28.
SherrJ. L.RuedyK. J.FosterN. C.PicheC. A.DuludeH.RickelsM. R.TamborlaneW. V.BethinK. E.DiMeglioL. A.FoxL. A.WadwaR. P.SchatzD. A.NathanB. M.MarcovinaS. M.RampakakisE.MengL.BeckR. W.for the TID Exchange Intranasal Glucagon Investigators. (2016). Glucagon nasal powder: A promising alternative to intramuscular glucagon in youth with type 1 diabetes. Diabetes Care, 39, 555–562. https://doi.org/10.2337/dc15-1606
29.
SnoekF. J.SpaepenE.NambuB. A.ChildC. J.BajpaiS.BalantacZ.BushnellD. M.PokrzywinskiR.MitchellB. D. (2022). Conversations and Reactions Around Severe Hypoglycemia (CRASH) study: Results from people with diabetes and caregivers in the United States. Clinical Diabetes, 40(4), 477–488. https://doi.org/10.2337/cd21-0131
30.
SpinaJ. L.McIntyreC. L.PulciniJ. A. (2012). An intervention to increase high school students’ compliance with carrying auto-injectable epinephrine: A MASNRN study. Journal of School Nursing, 28(3), 230–237. https://doi.org/10.1177/1059840511431459
YonkaitisC. F.JacobsJ. (2022). Undesignated glucagon in Illinois: An issue of access and equity. NASN School Nurse, 37(6), 331–336. https://doi.org/10.1177/1942602X221120820
